Table 1 Clinicopathological data on study population (invasive breast carcinoma)

From: Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade

Age

 Mean 61 years (range 28–87 years)

Follow-up time (years)

 Mean—14.6

 Median—15.5

 Range—6.3–20

Lymph node status

 Negative—142 (55%)

 Positive—88 (34.1%)

 Unknown—28 (10.9%)

Tumor size

 ≤2 cm—119 (46.1%)

 >2 cm—104 (40.3%)

 Unknown—35 (13.6%)

Modified Scarth-Bloom-Richardson tumor grade

 Grade 1–51 (19.8%)

 Grade 2–139 (53.9%)

 Grade 3–68 (26.4%)

Back to article page